Latest News - CX Daily News http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news CX Daily News - Latest News en BIBA Medical Ltd Thu, 09 Sep 2010 05:56:21 GMT http://blogs.law.harvard.edu/tech/rss 3360 Affino 5 RSS Generator webeditor@bibamedical.com The future of renal artery stenting is in peril http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/the-future-of-renal-artery-stenting-is-in-peril <div style="display:block;"> <div id="ItemTeaser1" style="float:left;"> On the final day of CX32, there was excitement and discussion at the Renal Session. The recent randomised trials which found that renal artery stenting showed no benefits over medical therapy, STAR and ASTRAL, came in for considerable criticism from some speakers. </div> </div> Thu, 15 Apr 2010 17:19:00 +0000 http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/the-future-of-renal-artery-stenting-is-in-peril Next generation of TEVAR devices under scrutiny http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/next-generation-of-tevar-devices-under-scrutiny <div style="display:block;"> <div id="ItemTeaser2" style="float:left;"> The new generation of devices and the indications by pathology were the subjects of the morning session in the main auditorium. One of the discussions was centred on whether the interests of physicians and manufacturers differ when developing thoracic devices. </div> </div> Mon, 12 Apr 2010 18:47:00 +0000 http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/next-generation-of-tevar-devices-under-scrutiny Vascular Access Course debuts at Charing Cross http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/vascular-access-course-debuts-at-charing-cross <div style="display:block;"> <div id="ItemTeaser3" style="float:left;"> The fifth international St George’s Vascular Access course, under the auspices of the Vascular Access Society, was held at Charing Cross for the very first time. The course yesterday focussed on the current debate on how best to rescue vascular access; is it by open, or endovascular means? </div> </div> Mon, 12 Apr 2010 18:32:00 +0000 http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/vascular-access-course-debuts-at-charing-cross CX Office Based Veins Course "studded with the stars of the venous world" http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/cx-office-based-veins-course-studded-with-the-stars-of-the-venous-world <div style="display:block;"> <div id="ItemTeaser4" style="float:left;"> The Charing Cross Office Based Veins Course 2010 is now in its third year and is now the biggest skills course of its kind in Europe. Ever-popular, this year’s course was packed with delegates eager to find out about the latest skills needed to treat varicose veins in an office environment. Nearly 200 people were trained in one day on 31 skills stations. </div> </div> Mon, 12 Apr 2010 18:22:00 +0000 http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/cx-office-based-veins-course-studded-with-the-stars-of-the-venous-world Landmark EVAR trials deliver new messages http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/landmark-evar-trials-deliver-new-messages <div style="display:block;"> <div id="ItemTeaser5" style="float:left;"> Key new messages from the long-term follow-up of the EVAR (United Kingdom Endovascular Aneurysm Repair) 1 and 2 trials were delivered yesterday. EVAR 1 showed that at 10 years, compared with open repair, EVAR has a lower operative mortality, but at six years the advantage of abdominal aortic aneurysm-related mortality is lost. Open repair does relatively better in the late stages because of a small number of EVAR ruptures. For patients physically too frail for open repair, the unique EVAR 2 </div> </div> Sun, 11 Apr 2010 18:10:00 +0000 http://www.cxvascular.com/dn-latest-news/cx-daily-news---latest-news/landmark-evar-trials-deliver-new-messages